Paul E. Schurr

696 total citations
14 papers, 361 citations indexed

About

Paul E. Schurr is a scholar working on Surgery, Molecular Biology and Biochemistry. According to data from OpenAlex, Paul E. Schurr has authored 14 papers receiving a total of 361 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Surgery, 6 papers in Molecular Biology and 6 papers in Biochemistry. Recurrent topics in Paul E. Schurr's work include Cholesterol and Lipid Metabolism (4 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers) and Peroxisome Proliferator-Activated Receptors (3 papers). Paul E. Schurr is often cited by papers focused on Cholesterol and Lipid Metabolism (4 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers) and Peroxisome Proliferator-Activated Receptors (3 papers). Paul E. Schurr collaborates with scholars based in United States, Russia and Austria. Paul E. Schurr's co-authors include John R. Schultz, Thomas M. Parkinson, Charles Day, Ronald B. Gammill, Stanislav Berjukow, Eva Margreiter, Rainer Marksteiner, Steffen Hering, Edward Perez‐Reyes and Daniel Lednicer and has published in prestigious journals such as The Journal of Physiology, Journal of Medicinal Chemistry and Toxicology and Applied Pharmacology.

In The Last Decade

Paul E. Schurr

14 papers receiving 314 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paul E. Schurr United States	8	125	101	72	64	54	14	361
Ho Won Seo South Korea	17	220 1.8×	56 0.6×	78 1.1×	64 1.0×	95 1.8×	29	547
Esther Sala Spain	11	208 1.7×	83 0.8×	32 0.4×	28 0.4×	44 0.8×	14	367
A.-K. Riethling Germany	4	185 1.5×	95 0.9×	29 0.4×	39 0.6×	44 0.8×	5	542
Nathalie Duhal France	13	105 0.8×	97 1.0×	69 1.0×	88 1.4×	38 0.7×	20	354
Erich Otto Graf Germany	9	111 0.9×	25 0.2×	108 1.5×	40 0.6×	44 0.8×	16	492
B. K. H. Tan Singapore	9	182 1.5×	71 0.7×	45 0.6×	33 0.5×	41 0.8×	12	553
J Dřímal Slovakia	12	146 1.2×	28 0.3×	40 0.6×	16 0.3×	81 1.5×	53	381
K Yashiro Japan	6	120 1.0×	123 1.2×	125 1.7×	42 0.7×	28 0.5×	10	365
Hartmut Kühn Germany	12	296 2.4×	30 0.3×	114 1.6×	41 0.6×	115 2.1×	16	701
Jacqueline Azay-Milhau France	8	149 1.2×	117 1.2×	67 0.9×	42 0.7×	43 0.8×	10	439

Countries citing papers authored by Paul E. Schurr

Since Specialization

Citations

This map shows the geographic impact of Paul E. Schurr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul E. Schurr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul E. Schurr more than expected).

Fields of papers citing papers by Paul E. Schurr

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul E. Schurr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul E. Schurr. The network helps show where Paul E. Schurr may publish in the future.

Co-authorship network of co-authors of Paul E. Schurr

This figure shows the co-authorship network connecting the top 25 collaborators of Paul E. Schurr. A scholar is included among the top collaborators of Paul E. Schurr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul E. Schurr. Paul E. Schurr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Marksteiner, Rainer, Paul E. Schurr, Stanislav Berjukow, et al.. (2001). Inactivation determinants in segment IIIS6 of Ca_v3.1. The Journal of Physiology. 537(1). 27–34. 40 indexed citations

Schurr, Paul E., et al.. (1985). Evaluation of timefurone, a new anti-atherosclerotic drug, for its effects on lipoprotein cholesterol in male SEA Japanese quail and rats. Atherosclerosis. 56(3). 313–321. 7 indexed citations

Gammill, Ronald B., Charles Day, & Paul E. Schurr. (1983). Khellin analogs. 1. General topological requirements for lipid-altering activity in furochromones. Journal of Medicinal Chemistry. 26(12). 1672–1674. 45 indexed citations

Schurr, Paul E., et al.. (1982). Hypobetalipoproteinemic agents. 3. Variation of the polycyclic portion of 4-(1-adamantyloxy)aniline. Journal of Medicinal Chemistry. 25(9). 1101–1103. 3 indexed citations

Stevens, Thomas J., et al.. (1981). Activity of ethyl 5-(p-chlorophenoxy)-3-hydroxy-3-methyl-pentanoate, a new hypocholesterolemic compound, in male rats and sea japanese quail. Atherosclerosis. 38(3-4). 411–416. 4 indexed citations

Lednicer, Daniel, et al.. (1979). Hypobetalipoproteinemic agents. 2. Compounds related to 4-(1-adamantyloxy)aniline. Journal of Medicinal Chemistry. 22(1). 69–77. 9 indexed citations

Day, Charles, et al.. (1978). Selected Animal Models for Systematic Antiatherosclerotic Drug Development. Advances in experimental medicine and biology. 109. 277–283. 2 indexed citations

Schurr, Paul E. & Charles Day. (1977). Response to the hypobetalipoproteinemic agent adamantyloxyphenyl piperidine in hyperlipemic rats. Lipids. 12(1). 22–28. 4 indexed citations

Schurr, Paul E., John R. Schultz, & Charles Day. (1976). High Volume Screening Procedures for Hypobetalipoproteinemic Activity in Rats. Advances in experimental medicine and biology. 67(0). 215–229. 13 indexed citations

10.

Day, Charles, et al.. (1976). Biological Activity of a Hypobetalipoproteinemic Agent. Advances in experimental medicine and biology. 231–249. 5 indexed citations

11.

Day, Charles, Paul E. Schurr, Daniel Emmert, Ruth E. TenBrink, & Daniel Lednicer. (1975). Hypo-.beta.-lipoproteinemic agents. 1. Bicyclo[2.2.2]octyloxyaniline and its derivatives. Journal of Medicinal Chemistry. 18(11). 1065–1070. 9 indexed citations

12.

Gray, Jack E., et al.. (1974). Drug-induced enteropathy characterized by lipid in macrophages. Toxicology and Applied Pharmacology. 27(1). 145–157. 2 indexed citations

13.

Schurr, Paul E., John R. Schultz, & Thomas M. Parkinson. (1972). Triton‐induced hyperlipidemia in rats as an animal model for screening hypolipidemic drugs. Lipids. 7(1). 68–74. 190 indexed citations

14.

Schurr, Paul E.. (1969). Composition and preparation of experimental intravenous fat emulsions.. PubMed. 29(1). 258–60. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact